Second International Pharmacoeconomic Conference on Alzheimer's disease

摘要: The Second International Pharmacoeconomic Conference on Alzheimer's Disease was held in Stockholm, Sweden, April 4, 2000. presentations focused the role of cognition pharmacoeconomic evaluations, costs and consequences behavioral disturbances, quality life, disease progression models, methods for valuing informal care. results from individual studies will be published separately. Cognition has been used as sole measure severity economic evaluations dementia. However, disturbances are an important determinant both cost life should also considered when appraising effect treatment. Quality-of-life assessment constitutes a single total impact disease, well way quantifying benefits treatment with antidementia drugs so that they can compared interventions other areas. Measuring patients dementia is associated methodologic difficulties related to some completing usual processes. models may helpful extrapolating clinical trials longer time periods more representative populations. Modeling unavoidable part evaluation drugs, efforts made increase transparency comparability among models. Informal care large percentage dementia, valuation these services evaluations. Difficulties lie spent caring elderly attaching correct price each unit time. contingent method alternative far not field